Posts tagged San Francisco
CU – Chicago funniest city in US
Apr 21st
According to a University of Colorado Boulder study, Chicago is the funniest city in the United States.
Boston is the No. 2 wise guy, followed by Atlanta in third place. Denver made the top 10 list at No. 8.
The study out today is the most comprehensive analysis of humorous cities and was led by Peter McGraw, associate professor of marketing and psychology at CU-Boulder’s Leeds School of Business. His team collected data across the nation using an algorithm created at his Humor Research Lab (HuRL).
According to the findings, the following are the top 10 funniest cities in the United States:
1. Chicago
2. Boston
3. Atlanta
4. Washington, D.C.
5. Portland, Ore.
6. New York
7. Los Angeles
8. Denver
9. San Francisco
10. Seattle
Source: CU
Buffs Lose Tight 4-2 Battle At San Francisco
Mar 26th
SAN FRANCISCO – The University of Colorado tennis team concluded a five-match road trip on Monday with a hard fought 4-2 loss to San Francisco.
“Today we came out and battled,” CU head coach Nicole Kenneally said. “Congrats to San Francisco, they were great. We battled, but we just weren’t quite as sharp as we’d liked to have been. We look forward to our home matches to end the season.”
Colorado and San Francisco split their all-time series 1-1, competing for the first time since the Buffs’ 7-0 blanking in 2007.
CU concludes its non-conference play with a 5-6 record, falling to 6-11 overall and holding a 1-5 record in the Pac-12 Conference. USF extends its winning streak to four to complete its 11-match home stand. With Monday’s win, the Dons become the first team in West Coast Conference with wins in the double digits.
The Buffs came out strong, claiming a doubles win for the first time since their 4-2 victory over Arizona on March 10. Juylette Steur and Erin Sanders breezed past Ka/Holmberg 8-2 for their seventh win of the season. In their first time competing as a pair, Winde Janssens and Dhany Quevedo battled, but fell 9-7 to Hashiguchi/Hadzi-Tanovic in the No. 2 doubles position.
CU continued to face stiff competition in singles play. All eight of CU’s most recent opponents have either been ranked, had at least one ranked player or both (as is the case for five of the teams). The Dons continued this streak, with Julyette Steur looking for her first win against a ranked player this season, after taking on her seventh straight ranked player in No. 76 Andrea Ka.
Junior Winde Janssens claimed her team-best 15th win of the season, moving to an impressive 12-5 record in dual play. Janssens defeated Sofia Holmberg 6-0, 6-0 for her second perfect match of the season (her first was over Northern Colorado’sStephanie Catlin on February 1).
Freshman Mazy Watrous also had a great showing, earning the third win of her career with a 7-5, 6-3 win over Brooke Irish. This was Watrous’ second win in straight sets.
The Buffs return to Boulder to round out the remainder of the regular season. CU begins the four-match home stand against Oregon. First serve is at 11 a.m. on Friday, March 29. Location is determinant on weather; stay tuned to CUBuffs.com for updates.
San Francisco 4, Colorado 2
USF (10-5, 1-2 WCC), CU (6-11, 1-5 Pac-12)
Monday, March 25
San Francisco, Calif.
1d) Steur/Sanders (CU) def. Ka/Holmberg, 8-2
2d) Hashiguchi/Hadzi-Tanovic (USF) def. Janssens/Quevedo, 9-7
3d) Irish/Nikolic (USF) def. Tiefel/Watrous, 8-3
Order of finish: 1, 3, 2
1s) No. 76 Andrea Ka (USF) def. Julyette Steur, 6-2, 6-2
2s) Winde Janssens (CU) def. Sofia Holmberg, 6-0, 6-0
3s) Milica Hadzi-Tanovic (USF) def. Erin Sanders, 6-2, 6-3
4s) Marina Nikolic (USF) def. Dhany Quevedo, 6-4, 6-4
5s) Mazy Watrous (CU) def. Brooke Irish, 7-5, 6-3
6s) Ashley Tiefel (CU) vs. Yurie Hashiguchi (USF), 6-0, 3-6, 1-3 (DNF)
Order of finish: 1, 2, 3, 5, 4
[includeme src=”http://c1n.tv/boulder/media/bouldersponsors.html” frameborder=”0″ width=”670″ height=”300″]
CU : Some good news for doggie lovers
Dec 11th
clinical study to treat canine pain
A University of Colorado Boulder professor and her biomedical spinoff company Xalud Therapeutics Inc. of San Francisco are teaming up with a Front Range veterinarian to conduct a clinical study targeting an effective treatment for dogs suffering from chronic pain.
Distinguished Professor Linda Watkins of CU-Boulder’s psychology and neuroscience department said the study involves treating ailing dogs with a gene therapy using Interleukin-10, or IL-10, a protein and anti-inflammatory that both dogs and humans produce naturally. Watkins is working with veterinarian Robert Landry of Mountain Ridge Animal Hospital and Pain Management Center in Lafayette, who will be treating canine patients suffering from chronic and painful conditions, some of which already are being treated with various other medications with limited success.
Animals perceive and experience several levels of pain that are similar to humans, and chronic pain can be debilitating and also shorten the lives of pets, said Landry, one of only a handful of credentialed American Academy of Pain Management practitioners in Colorado. Landry currently is seeking Denver-Boulder area pet owners who have dogs suffering from chronic pain and who might be interested in participating in the study, which is free.
The new study is driven by research spearheaded by Watkins indicating a type of cell known as glial cells found in the nervous system of mammals plays a key role in pain. Under normal conditions, glial cells act as central nervous system “housekeepers,” cleaning up cellular debris and providing support for neurons, said Watkins. But glial cells also can play a pivotal role in pain enhancement by exciting neurons that both transmit pain signals and release a host of chemical compounds that cause problems like chronic neuropathic pain and other medical issues.
The team will use Xalud’s lead product candidate, XT-101, a gene therapy that harnesses the power of the potent anti-inflammatory IL-10 to normalize glial activity and eliminate neuropathic pain for up to 90 days with a single injection.
The gene therapy based on IL-10 has a number of advantages, including suppressing glial activity in the spinal cord, stimulating tissue regeneration and growth, decreasing the production of pro-inflammatory substances and increasing the production of anti-inflammatory substances, Watkins said. Landry and Watkins also have been working with the American Kennel Club on potential funding for additional clinical studies involving the treatment of chronic pain in dogs, said Watkins.
“We have already tested this new therapy in two pet dogs, and both have had remarkable reversals of their pain for long durations after a single injection of the therapeutic,” she said. “Our early peek at the potential of this therapeutic treatment in dogs shows essentially the same positive effects we have seen in laboratory rats used in our studies that have been treated with the therapy.”
Watkins said demonstrating the efficacy and safety of the new gene therapy in a second species of mammal is important in terms of moving it forward to eventually meet FDA regulations for human clinical trials.
In addition to studying what triggers glial cells to become activated and begin releasing pain-enhancing substances and ways to control chronic pain, Watkins and her research team recently discovered that clinically prescribed opioids also activate glial cells and cause them to release pain-enhancing substances. “Our ultimate goal is to find a means by which clinical pain control can be improved so as to relieve human suffering,” she said.
To contact Landry about possible participation in the study by family dogs suffering chronic pain and that might benefit from the experimental treatment, call the Mountain Ridge Animal Hospital at 303-665-4852.
For more information on CU-Boulder’s psychology and neuroscience department visit http://psych-www.colorado.edu/. For more information on Xalud Therapeutics Inc. visit http://www.xaludthera.com/. For more information on Mountain Ridge Animal Hospital visit http://www.mountainridgevet.com/.
[includeme src=”http://c1n.tv/boulder/media/bouldersponsors.html” frameborder=”0″ width=”670″ height=”300″]
–